Results 151 to 160 of about 21,234 (200)

A study on the distribution of BK and JC polyomavirus in discarded donor kidneys. [PDF]

Front Transplant
Moest WT, de Vries APJ, Lalai RA, Baelde HJ, Kers J, Wessels E, Doppenberg JB, Engelse MA, Feltkamp MCW, Rotmans JI.   +9 more
europepmc   +1 more source

Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD). [PDF]

Diagnostics (Basel)
Kimura K, Hayashi K, Sato M, Nakaya Y, Suzuki A, Takaku N, Hayashi H, Hayashi K, Miura T, Kobayashi Y.   +9 more
europepmc   +1 more source

Delayed Posthypoxic Leukoencephalopathy in a Catatonic-Appearing Patient: A Case Report. [PDF]

Case Rep Psychiatry
Bentley M, Gaal J, Hostetter J, Holroyd S, Pickstone J, Melvin K.   +5 more
europepmc   +1 more source

Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers. [PDF]

Viruses
Pocora MM, Bini P, Berzero G, Vegezzi E, Diamanti L, Gastaldi M, Cinque P, Catalano G, Paoletti M, Pichiecchio A, Tartara F, Basso S, Baldanti F, Furione M, Comoli P, Marchioni E.   +15 more
europepmc   +1 more source

Error in Author Affiliation.

JAMA Neurol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy.

Neurology, 2023
JC polyomavirus (JCV) establishes an asymptomatic latent and/or persistent infection in most of the adult population. However, in immunocompromised individuals, JCV can cause a symptomatic infection of the brain, foremost progressive multifocal ...
Finja Schweitzer, S. Laurent, I. Cortese, G. Fink, S. Silling, T. Skripuletz, I. Metz, M. Wattjes, C. Warnke   +8 more
semanticscholar   +1 more source

Outcome of Progressive Multifocal Leukoencephalopathy Treated by Interleukin‐7

Annals of Neurology, 2022
Restoring anti‐JC virus (JCV) immunity is the only treatment of progressive multifocal leukoencephalopathy (PML). Interleukin‐7 is a cytokine that increases number and function of T cells. We analyzed a population of PML patients who received recombinant
Rébecca Lajaunie, Ilaria Mainardi, J. Gasnault, V. Rousseau, A. Tarantino, A. Sommet, P. Cinque, G. Martin-Blondel   +7 more
semanticscholar   +1 more source

Progressive Multifocal Leukoencephalopathy

Neurologic Clinics, 1984
PML is a progressive opportunistic infection of the CNS caused by a commonly occurring virus that may become manifest in the context of reduced host resistance in persons of any age. The authors review the disease and its causes, including a discussion of treatment attempts and differential diagnoses.
B R, Brooks, D L, Walker
openaire   +4 more sources